Praluent 75 mg/mL pre-filled pen Images
Generic Name: alirocumab
This medication has been identified as Praluent 75 mg/mL pre-filled pen. It is supplied by Regeneron Pharmaceuticals, Inc.
Praluent is used in the treatment of High Cholesterol, Familial Heterozygous; Cardiovascular Risk Reduction; High Cholesterol; High Cholesterol, Familial Homozygous and belongs to the drug class PCSK9 inhibitors. Praluent 75 mg/mL pre-filled pen is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Praluent
- Generic Name
- alirocumab
- Strength
- 75 mg/mL pre-filled pen
- Availability
- Prescription only
- Drug Class
- PCSK9 inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Regeneron Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 61755-0020
More about Praluent (alirocumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (283)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: PCSK9 inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
